XML 38 R25.htm IDEA: XBRL DOCUMENT
v3.8.0.1

COLLABORATIVE ARRANGEMENTS (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2017
COLLABORATIVE ARRANGEMENTS |
Schedule of revenue from collaborative arrangements |
|  | Year Ended December 31, |
(In thousands) |  | 2017 |  | 2016 |  | 2015 |
Royalties from a related party—RELVAR/BREO |  | $ | 198,726 |  | $ | 128,638 |  | $ | 59,188 |
Royalties from a related party—ANORO |  |  | 29,036 |  |  | 17,869 |  |  | 7,699 |
Royalties from a related party—TRELEGY |  |  | 179 |  |  | — |  |  | — |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total royalties from a related party |  |  | 227,941 |  |  | 146,507 |  |  | 66,887 |
Less: amortization of capitalized fees paid to a related party |  |  | (13,823 | ) |  | (13,823 | ) |  | (13,823 | )
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Royalty revenue |  |  | 214,118 |  |  | 132,684 |  |  | 53,064 |
Strategic alliance—MABA program license |  |  | 3,099 |  |  | 885 |  |  | 885 |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total net revenue from GSK |  | $ | 217,217 |  | $ | 133,569 |  | $ | 53,949 |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​

X
- References No definition available. + Details
Name: | inva_CollaborationArrangementsDisclosureAbstract
Namespace Prefix: | inva_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of revenue recognition by the entity related to collaboration agreement. + References No definition available. + Details
Name: | inva_CollaborativeArrangementRevenueRecognitionTableTextBlock
Namespace Prefix: | inva_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration